New Data Published in Gastroenterology Demonstrate the Power of Fluidigm’s Imaging Mass Cytometry on the Hyperion Imaging System to Identify Novel Targets for Pancreatic Cancer Therapy

Ads

You May Also Like

Pernix Therapeutics Appoints Two Board Members

MORRISTOWN, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a ...

NANOBIOTIX appoints senior executive from pharmaceutical industry, as Chief Operating Officer

  Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer Oncology industry ...